These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 3510364
1. Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects. Shargill NS, Tatoyan A, Fukushima M, Antwi D, Bray GA, Chan TM. Metabolism; 1986 Jan; 35(1):64-70. PubMed ID: 3510364 [Abstract] [Full Text] [Related]
2. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats. Chang AY, Wyse BM, Gilchrist BJ, Peterson T, Diani AR. Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790 [Abstract] [Full Text] [Related]
3. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice. Chang AY, Wyse BM, Gilchrist BJ. Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791 [Abstract] [Full Text] [Related]
4. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice. Chang AY, Gilchrist BJ, Wyse BM. Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280 [Abstract] [Full Text] [Related]
5. Ciglitazone, a hypoglycemic agent: early effects on the pancreatic islets of ob/ob mice. Colca JR, Wyse BM, Sawada G, Jodelis KS, Connell CL, Fletcher-McGruder BL, Palazuk BJ, Diani AR. Metabolism; 1988 Mar; 37(3):276-80. PubMed ID: 3278192 [Abstract] [Full Text] [Related]
6. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. Kraegen EW, James DE, Jenkins AB, Chisholm DJ, Storlien LH. Metabolism; 1989 Nov; 38(11):1089-93. PubMed ID: 2682137 [Abstract] [Full Text] [Related]
7. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. Stevenson RW, Hutson NJ, Krupp MN, Volkmann RA, Holland GF, Eggler JF, Clark DA, McPherson RK, Hall KL, Danbury BH. Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074 [Abstract] [Full Text] [Related]
8. Glucose transport and metabolism in the perfused hindquarters of lean and obese-hyperglycemic (db/db) mice. Effects of insulin and electrical stimulation. Chan TM, Tatoyan A. Biochim Biophys Acta; 1984 Apr 24; 798(3):325-32. PubMed ID: 6424725 [Abstract] [Full Text] [Related]
9. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Fujita T, Sugiyama Y, Taketomi S, Sohda T, Kawamatsu Y, Iwatsuka H, Suzuoki Z. Diabetes; 1983 Sep 24; 32(9):804-10. PubMed ID: 6354788 [Abstract] [Full Text] [Related]
10. Adrenalectomy reverses insulin resistance in muscle from obese (ob/ob) mice. Ohshima K, Shargill NS, Chan TM, Bray GA. Am J Physiol; 1984 Feb 24; 246(2 Pt 1):E193-7. PubMed ID: 6421176 [Abstract] [Full Text] [Related]
11. Ciglitazone, a new hypoglycaemic agent. 4. Effect on pancreatic islets of C57BL/6J-ob/ob and C57BL/KsJ-db/db mice. Diani AR, Peterson T, Sawada GA, Wyse BM, Gilchrist BJ, Hearron AE, Chang AY. Diabetologia; 1984 Aug 24; 27(2):225-34. PubMed ID: 6386585 [Abstract] [Full Text] [Related]
12. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H. Diabetes; 1988 Nov 24; 37(11):1549-58. PubMed ID: 3053303 [Abstract] [Full Text] [Related]
13. Effects of dexamethasone on glucose transport by skeletal muscles of obese (ob/ob) mice. Ohshima K, Shargill NS, Chan TM, Bray GA. Int J Obes; 1989 Nov 24; 13(2):155-63. PubMed ID: 2491515 [Abstract] [Full Text] [Related]
14. Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice. Cuendet GS, Loten EG, Jeanrenaud B, Renold AE. J Clin Invest; 1976 Nov 24; 58(5):1078-88. PubMed ID: 993331 [Abstract] [Full Text] [Related]
15. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action. Zierath JR, Ryder JW, Doebber T, Woods J, Wu M, Ventre J, Li Z, McCrary C, Berger J, Zhang B, Moller DE. Endocrinology; 1998 Dec 24; 139(12):5034-41. PubMed ID: 9832442 [Abstract] [Full Text] [Related]
16. Effects of ciglitazone on insulin resistance and thermogenic responsiveness to acute cold in brown adipose tissue of genetically obese (ob/ob) mice. Mercer SW, Trayhurn P. FEBS Lett; 1986 Jan 20; 195(1-2):12-6. PubMed ID: 3510900 [Abstract] [Full Text] [Related]
17. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth. Towns R, Kostyo JL, Colca JR. Endocrinology; 1994 Feb 20; 134(2):608-13. PubMed ID: 8299559 [Abstract] [Full Text] [Related]
18. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse. Cameron CM, Kostyo JL, Adamafio NA, Dunbar JC. Endocrinology; 1987 Apr 20; 120(4):1568-75. PubMed ID: 3549265 [Abstract] [Full Text] [Related]
19. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA. Diabetes; 1995 Sep 20; 44(9):1087-92. PubMed ID: 7657033 [Abstract] [Full Text] [Related]
20. Amelioration by KRP-297, a new thiazolidinedione, of impaired glucose uptake in skeletal muscle from obese insulin-resistant animals. Murakami K, Tsunoda M, Ide T, Ohashi M, Mochizuki T. Metabolism; 1999 Nov 20; 48(11):1450-4. PubMed ID: 10582556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]